Breast Cancer News and Research

Latest Breast Cancer News and Research

PAM50 potentially simplifies underlying breast tumor biology

On September 23, researchers published online in the journal Nature a study of the molecular biology of breast cancer, using the intrinsic subtypes as defined by the PAM50 gene signature as an organizing framework for analyzing genomic and proteomic aberrations. This landmark study both underscores the emergence of the intrinsic subtypes as a powerful taxonomy of breast cancer in research, and PAM50's role as the gold standard for categorizing breast cancer by subtype.

From NanoString Technologies 25 Sep 2012

Protect Your Manhood, ZERO collaborate to address prostate health

ZERO – The End of Prostate Cancer is partnering with Protect Your Manhood, a New Hampshire seacoast based start-up founded by prostatitis survivor and marketing maven Chris Sargent, which offers a culturally relevant resource to promote prostate health.

25 Sep 2012

Molecular similarity between one sub-type of breast cancer and ovarian cancer

A team of scientists with The Cancer Genome Atlas program reports their genetic characterization of 800 breast tumors, including finding some of the genetic causes of the most common forms of breast cancer, providing clues for new therapeutic targets, and identifying a molecular similarity between one sub-type of breast cancer and ovarian cancer.

24 Sep 2012

Vitamin D deficiency affects more Australians than previously thought

September marks the start of spring but new research reveals it is also the month when Australians’ vitamin D levels are at their lowest ebb.

24 Sep 2012

Latest research on stem cells discussed at Einstein symposium

The promise of stem cells seems limitless. If they can be coaxed into rebuilding organs, repairing damaged spinal cords and restoring ravaged immune systems, these malleable cells would revolutionize medical treatment. But stem cell research is still in its infancy, as scientists seek to better understand the role of these cells in normal human development and disease.

24 Sep 2012

Most basal-like breast and ovarian tumors have similar genetic origins

The most comprehensive analysis yet of breast cancer shows that one of the most deadly subtypes is genetically more similar to ovarian tumors than to other breast cancers.

24 Sep 2012

ASTRO's Annual Meeting to be held in Boston from Oct. 28-31

ASTRO's Annual Meeting is the premier scientific meeting in radiation oncology and is expected to attract more than 11,000 attendees including oncologists from all disciplines, medical physicists, dosimetrists, radiation therapists, radiation oncology nurses and nurse practitioners, biologists, physician assistants, practice administrators, industry representatives and other health care professionals from around the world.

24 Sep 2012

UAB urges women to get tested for key measures throughout their lives

Heart disease, cancer and stroke are the leading causes of death in women of all ages in the United States, according to the Centers for Disease Control and Prevention. To get ahead of these chronic health issues and possibly prevent them from worsening, experts at the University of Alabama at Birmingham urge women to get tested for key measures throughout their lives.

21 Sep 2012

Research focuses on HER2 cancers

As scientists continue to map breast cancer's complex genetic makeup, research at Michigan State University could lead to better diagnoses and new treatment targets.

21 Sep 2012

Data from Navidea’s Lymphoseek Phase 3 studies on solid tumors to be presented at ESSO

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its completed Phase 3 Lymphoseek studies in breast cancer and melanoma are being presented at the 32nd Congress of the European Society of Surgical Oncology (ESSO) in Valencia, Spain, from September 19-21, 2012.

21 Sep 2012

Boehringer Ingelheim files MAA with EMA for afatinib approval

Today, Boehringer Ingelheim has announced the submission of a Marketing Authorisation Application to the European Medicines Agency (EMA) for approval of afatinib, the first irreversible ErbB Family Blocker, as a treatment for patients with EGFR (ErbB1) mutation positive non-small cell lung cancer (NSCLC). Afatinib has demonstrated unprecedented efficacy versus chemotherapy in the Phase III LUX-Lung 3 registration trial, which provides pivotal support for this submission.

20 Sep 2012

Light alcohol consumption may increase risk of certain cancers

The majority of observational studies have shown that alcohol intake, especially heavy drinking, increases a number of upper-aero-digestive tract (UADT) and other cancers, and even moderate drinking is associated with a slight increase in the risk of breast cancer.

19 Sep 2012

Positive data from Nektar’s NKTR-192 Phase 1a study on acute pain

Nektar Therapeutics announced today that positive data from the first single-ascending dose Phase 1a clinical study of NKTR-192, the company's novel short-acting mu-opioid analgesic candidate, demonstrate that the drug candidate achieved its target pharmacokinetic profile.

19 Sep 2012

U-Systems receives FDA approval for somo-v ABUS

The U.S. Food and Drug Administration today approved the first ultrasound device for use in combination with a standard mammography in women with dense breast tissue who have a negative mammogram and no symptoms of breast cancer.

19 Sep 2012

AACR International Conference on Frontiers in Cancer Prevention Research to be held from Oct. 16-19

The 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research will bring together scientists, survivors and patient advocates to share the latest science on cancer prevention.

18 Sep 2012

Vitamin E may prevent cancer in patients with Cowden Syndrome

Cleveland Clinic researchers have discovered that vitamin E may prevent cancer in patients with an under-recognized genetic disorder.

18 Sep 2012

Ionizing radiation imaging raises breast cancer risk in BRCA1/2 carriers

Exposure to ionizing radiation at an early age increases the risk for breast cancer among women with BRCA1/2 mutations, reveals research published in the BMJ.

17 Sep 2012

PARP inhibitors may be novel treatment strategy in women with HER2-positive breast cancers

Poly (ADP-Ribose) polymerase (PARP) inhibitors, shown to have clinical activity when used alone in women with familial breast and ovarian cancers linked to BRCA mutations, may be a novel treatment strategy in women with HER2-positive breast cancers, according to the results of a study published in Cancer Research, a journal of the American Association for Cancer Research.

17 Sep 2012

WWE announces partnership with Susan G. Komen for the Cure

WWE today announced a partnership with Susan G. Komen for the Cure featuring WWE Superstar John Cena co-branded, pink and black ring gear, which will be debuted at tonight's Night of Champions pay-per-view event in Boston. Cena will wear the Special Edition gear through October in honor of breast cancer awareness month.

17 Sep 2012

Study could reveal whether breast cancer patients with BRCA mutations are responsive to Veliparib

Ongoing research at the Methodist Cancer Center could reveal whether metastatic breast cancer patients with BRCA gene mutations are particularly responsive to a drug regimen that includes Veliparib, an investigational drug believed to hamper cancer cells.

15 Sep 2012

Breast Cancer News and Research

Latest Breast Cancer News and Research

PAM50 potentially simplifies underlying breast tumor biology

Protect Your Manhood, ZERO collaborate to address prostate health

Molecular similarity between one sub-type of breast cancer and ovarian cancer

Vitamin D deficiency affects more Australians than previously thought

Latest research on stem cells discussed at Einstein symposium

Most basal-like breast and ovarian tumors have similar genetic origins

ASTRO's Annual Meeting to be held in Boston from Oct. 28-31

UAB urges women to get tested for key measures throughout their lives

Research focuses on HER2 cancers

Data from Navidea’s Lymphoseek Phase 3 studies on solid tumors to be presented at ESSO

Boehringer Ingelheim files MAA with EMA for afatinib approval

Light alcohol consumption may increase risk of certain cancers

Positive data from Nektar’s NKTR-192 Phase 1a study on acute pain

U-Systems receives FDA approval for somo-v ABUS

AACR International Conference on Frontiers in Cancer Prevention Research to be held from Oct. 16-19

Vitamin E may prevent cancer in patients with Cowden Syndrome

Ionizing radiation imaging raises breast cancer risk in BRCA1/2 carriers

PARP inhibitors may be novel treatment strategy in women with HER2-positive breast cancers

WWE announces partnership with Susan G. Komen for the Cure

Study could reveal whether breast cancer patients with BRCA mutations are responsive to Veliparib

Industry Focus eBook - Oncology (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in